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 1 
INTRODUCTION
 
Hepatocellular carcinoma accounts for 80% to 90% of primary 
liver cancer. Hepatocellular carcinoma is a major health problem 
worldwide, with an estimated incidence ranging between 500,000 and 
1,000,000 new cases annually. It is the fifth most common cancer in 
the world, and the third most common cause of cancer-related death
 1)
. 
The rates of hepatocellular carcinoma in men are 2 to 4 times higher 
than in women. It usually develops between 35 and 65 years of age, 
when people are most productive and have most family 
responsibilities
 2, 3, 4, 5)
. Hepatocellular carcinoma shows great 
geographical variation, with a very high incidence in Asia and 
sub-Saharan Africa
 6)
. Although its incidence is far lower in the United 
States and Europe, those rates have been increasing in recent years. 
There are many treatment options for hepatocellular carcinoma, 
such as liver resection (partial hepatectomy and orthotopic liver 
transplantation), local ablative therapy (injection of cytotoxic agent 
and application of an energy source), hepatic artery transcatheter 
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treatment (transarterial chemoembolisation and transarterial 
radioembolisation), systemic therapy (chemotherapy, immunotherapy, 
chemo-immunotherapy, hormonal therapy and somatostation 
analogue) and other treatments (gene therapy and supportive therapy). 
The most effective and potentially curative therapy is liver 
transplantation, because it eradicates the hepatocellular carcinoma, 
however, this option is available to a very small fraction of 
hepatocellular carcinoma patients whose tumors are discovered at a 
very early stage before there is multifocal or vascular involvement
 7)
. 
The other options used in clinic also depend on the status of the 
tumors. Combination chemotherapy appeared promising in two phase 
II studies of cisplatin, interferon, doxorubicin, and 5-fluorouracil
 8, 9)
 
and was notable for a small, but significant, number of pathologic 
complete remissions discovered after tumor downstaging (patients 
were all deemed unresectable as a criterion for entering the study) 
allowed surgical resection. Therefore, it is important to find a new 
drug for chemotherapy in the future
 7, 10, 11, 12, 13, 14)
. 
For thousands of years, natural products have played an 
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important role throughout the world in treating and preventing human 
diseases. Natural product medicines have come from various source 
materials including terrestrial plants, terrestrial microorganisms, 
marine organisms, and terrestrial vertebrates and invertebrates
 15)
. The 
importance of natural products in modern medicine has been discussed 
in recent reviews and reports
 15, 16, 17, 18)
. The value of natural products 
in this regard can be assessed using 3 criteria: (1) the rate of 
introduction of new chemical entities of wide structural diversity, 
including serving as templates for semisynthetic and total synthetic 
modifi cation, (2) the number of diseases treated or prevented by these 
substances, and (3) their frequency of use in the treatment of disease.  
Scrutiny of medical indications by source of compounds has 
demonstrated that natural products and related drugs are used to treat 
87% of all categorized human diseases, including as antibacterial, 
anticancer, anticoagulant, antiparasitic, and immunosuppressant agents, 
among others. Moreover, there are more than 60% of drugs of natural 
origin used in the treatment of cancer
 15)
. Recently, the low side effects 
of natural products in anticancer treatment have been noticed. Hence, 
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finding a new natural source with anticancer activities would aid in 
finding new tools for cancer therapy. 
In this study, we aimed to investigate the anticancer activity and 
mechanism of action of Zizyphus jujuba Mill (Z. jujuba), a natural 
product, in human liver cancer cells (HepG2 cells). To achieve this 
aim, the following studies were conducted.  
In Chapter I, we described that the chloroform fractions from Z. 
jujuba extract (CHCl3-F) induced a concentration dependent effect on 
apoptosis and a differential cell cycle arrest in HepG2 cells. 
In Chapter II, we described that combination of CHCl3-F and 
green tea extracts (GTE) produced an enhanced cell growth inhibition 
effect, and the resultant G1 arrest was caused via different mechanism 
as that of CHCl3-F treatment alone in HepG2 cells. 
In Chapter III, we described that CHCl3-F and GTE enhanced 
anti-cancer activity was via reducing the expression of APRIL, 
moreover, the anti-cancer activity of CHCl3-F and GTE mixture was 
stronger than that of the anti-cancer drug cisplatin in HepG2 cells. 
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CHAPTER I 
 
Mechanism of the anticancer activity of Zizyphus jujuba  
in HepG2 cells 
 
1. Introduction 
Chinese date is scientifically known as Zizyphus jujuba Mill (Z. 
jujuba). It is also “Hongzao” or “Dazao” in China and “Natume” in 
Japan. It has been mentioned in the famous Chinese ancient medical 
book- Sheng Nong Ben Cao Jing, and has traditionally been used in 
oriental medicines. For example, in Chinese traditional medicine, the 
dried fruits are prescribed as anodyne, anti-tumor, pectoral, refrigerant, 
sedative, stomachic, styptic and tonic. In Japan, the extracts of Z. jujuba 
are used to treat chronic hepatitis or distress and fullness in the chest 
and ribs. Some studies reported that there are 11 major components of 2 
saponins and 9 fatty acids, namely jujuboside A, jujuboside B, lauric 
acid, myristic acid, palmitic acid, palmitoleic acid, stearic acid, oleic 
acid, linoleic acid, arachidic acid and docosanoic acid in Z. jujuba. 
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Many physiological activities have been found but there are no report 
about the anticancer activity of these components
 19, 20, 21)
. A study 
reported the ethyl acetate-soluble fraction of Z. jujuba showed high 
cytotoxic activity against some tumor cell lines
 22)
. However, in these 
studies the mechanism of action of Z. jujuba has not so far been 
investigated. More importantly, the effect of Z. jujuba in human 
hepatoma cells (HepG2 cells), which come from hepatocellular 
carcinoma, has not yet been reported.  
In this Chapter, we investigated the anticancer activity and 
mechanism of action of Z. jujuba in HepG2 cells. 
 
2. Materials and Methods 
2.1. Materials  
Z. jujuba extract was kindly donated from Sea Load Co. Ltd. 
(Fukui, Japan). 2’, 7’- Dichlorodihydrofluorescein diacetate 
(DCFH-DA) and rhodamine 123 were purchased from
 
Sigma–Aldrich 
Fine Chemical (Tokyo, Japan). Rb (retinoblastoma protein) and p27
Kip1 
antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa 
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Cruz, CA, USA). Fetal bovine serum (FBS) was purchased from 
Equitech-Bio Inc. (Kerrville, Texas, USA). Other chemicals used in this 
chapter were special grade commercial products. 
 
2.2. Cell culture 
HepG2 cells were cultured in Dulbecco’s modified Eagle’s 
medium supplemented with 10% FBS in humidified incubator 
containing 5% CO2 in air at 37C. The cells were washed and cultured 
again at a concentration of 2×10
5
/ml in fresh medium. Z. jujuba extract 
was diluted in the culture medium immediately before use. In all the 
experiments, control cultures were made up of medium, water and the 
cells only. 
 
2.3. Cell viability 
Cell viability was determined with the neutral red uptake assay, 
based on the lysosomal uptake of neutral red
 23)
. Following specified 
incubations with test agents, neutral red solution
 
(0.25 mg/ml) was 
added to the cell cultures at a final concentration of 50 µg/ml. After 
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incubation at 37°C for 2 hrs, cells were rinsed twice with a mixture of 
1% (v/v) formaldehyde, 1% (v/v) calcium chloride, and 98% (v/v) 
distilled water. Subsequently, 1 ml of destaining buffer
 
consisting of 1% 
(v/v) acetic acid, 50% (v/v) ethanol, and 49%
 
(v/v) distilled water was 
added to the cells, and the culture
 
plates were kept for 30 mins. 
Lysosomal
 
uptake of neutral red was determined spectrophotometrically 
at
 
540 nm
 24, 25, 26)
. Viability was expressed as (A540-treated cells/A540
 
of 
appropriate control) × 100% after correction for background
 
absorbance 
(100% cytotoxicity). 
 
2.4. Fractionation of Z. jujuba extract   
Z. jujuba extract was diluted at 1/20 with water. These liquids 
were extracted with chloroform, followed by ethyl acetate, butanol and 
water. Each of the fractions was evaporated to dryness in vacuo (Fig. 
2). 
 
2.5. Cell cycle assay 
The cell cycle distribution was analyzed by laser scanning 
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cytometer (Olympus LSC 101) using PI staining. Briefly, after 
designated treatment, cells were washed twice in PBS and incubated 
with freshly prepared PI-stained buffer (0.1% Triton X-100 in PBS, 20 
µg/ml PI, 200 µg/ml RNase) for 1 hr at 37°C in the dark
 27)
. 
 
2.6. Reactive oxygen species (ROS) assay   
The generation of ROS was determined with the DCFH-DA 
reagent as described by Ablise, M.
 28)
. Briefly, DCFH-DA (8 μM) was 
added at the last 15 mins of Z. jujuba extract treatment. Cells were 
washed with PBS twice and resuspended in Hanks 
solution.  Fluorescence intensity was measured using a micro-plate 
reading fluoroscan plate-reader (Wallac 1420 ArVOsx, Amarsham 
Pharmacia Biotech) with the excitation wavelength at 485 nm and the 
emission wavelength at 535 nm
 29, 30)
. The amount of intracellular ROS 
was calculated from a standard curve derived from 2’, 7’ 
–dichlorofluoresceina (DCF). Protein concentration was measured by 
the Bradford method
 31)
.  
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2.7. Mitochondrial membrane potential assay  
The HepG2 cells were incubated with Z. jujuba extract for 30, 
60, 120 and 240 mins and rhodamine 123 (10 µg/ml) was added at the 
last 30 mins of Z. jujuba treatment. Cells were washed twice with PBS 
and fixed with 4% p-formaldehyde. After washing with PBS, the 
fluorescence intensity of cells was measured by a micro-plate reading 
fluoroscan plate-reader with the excitation wavelength at 505 nm and 
the emission wavelength at 525 nm
 32)
.  
 
2.8. Western blot analysis of Rb and p27
Kip1 
Cells were harvested at the indicated time points and were 
washed twice in PBS. Then the cells were dissolved for 30 mins with
 
lysis buffer (150 mM NaCl, 50 mM Tris
 
(pH 7.2), 1 mM EDTA, 0.5% 
sodium deoxycholate, 1% Nonidet P-40, 1 mM sodium vanadate, 1 
mM NaF, 20 µg/mL
 
aprotinin, 50 µg/mL leupeptin, 10 µg/mL
 
Pepstatin A and 100 µg/mL phenylmethylsulfonyl
 
fluoride). Finally, 
the solution was centrifuged at 2000 ×g for 20 mins at 4°C. The 
supernatant was collected and protein concentrations were determined 
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by Bradford method. Equal amounts of protein were fractionated on 
10% SDS-PAGE gels and
 
transferred to 0.45 µm PVDF
 
(Hybond; 
Amersham Pharmacia Biotech). After blocking overnight in 0.1% 
Tween-20
 
and 5% non-fat dry milk, in PBS, blots were incubated with 
anti-Rb antibody or anti-p27
Kip1 
antibody for 1 hr at room temperature. 
After washing, the membrane was reincubated with 1:750 diluted 
biotinulated mouse immunoglobulin G (IgG) or rabbit IgG for 1 hr at 
room temperature. The membrane was washed several times, and 
incubated with 1:750 diluted horse radish peroxidase-coupled 
streptavidin for 1 hr at room temperature. After several washing steps, 
the color reaction was developed with DAB. Densitometry analysis of 
the protein bands was performed with the software Scion Image 
(Scion Corporation). 
 
2.9. Statistical analysis  
Data are represented as means ± S.D. (standard deviation from 
the mean). The significance of difference in assay values was 
evaluated with ANOVA followed by Tukey multiple tests. p <0.05 was 
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used to indicate a statistically significant difference. 
 
3. Results 
3.1. Effect of Z. jujuba extract on cell viability  
The effect of Z. jujuba on cell viability was examined in HepG2 
cells by neutral red method. As shown in Fig. 1, Z. jujuba extract 
decreased cell viability in a dose-dependent manner. The Z. jujuba 
extract contains many substances such as protein, carbohydrate and 
minerals (Data are not shown), and it has been reported that the ethyl 
acetate-soluble fraction of Z. jujuba has high cytotoxic activity
 22)
. 
Therefore, we extracted the Z. jujuba extract again by organic solvent 
(Fig. 2), and examined the cell viability with these fractions from the 
original Z. jujuba extract in HepG2 cells. As shown in Fig. 3, the 
chloroform fraction of Z. jujuba extract (CHCl3-F) decreased cell 
viability the most as compared with the other fractions and non-treated 
control cells, in a dose-dependent manner (Fig. 4). Hence, this fraction 
was used in subsequent experiments. 
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3.2. Cell cycle changes with CHCl3-F   
We evaluated cell cycle dynamics with PI staining to examine 
the effect of CHCl3-F induced decrease of the cell viability in HepG2 
cells. As shown in Fig. 5, cells incubated with 100 µg/ml of CHCl3-F 
resulted in an accumulation of G1 cell cycle region and a decrease in S 
cell cycle region. However, the cell number of G2/M phase was 
increased by the addition of 200 µg/ml of the CHCl3-F, suggesting that 
the cell cycle was arrested at G2/M phase. Furthermore, CHCl3-F also 
increased the cell number of Sub-G1 phase, suggesting that the 
CHCl3-F also induced apoptosis in HepG2 cells.  
 
3.3. Effect of CHCl3-F on intracellular ROS levels  
In recent years many studies on apoptosis have been associated 
with the excessive production of reactive oxygen
 
species (ROS). We 
examined the effect of CHCl3-F on intracellular peroxides levels by 
the DCFH-DA method. As shown in Fig. 6, the intracellular ROS level 
increased rapidly when cells were incubated with 100 µg/ml of 
CHCl3-F at 15 mins, but not with 200 µg/ml of the CHCl3-F. These 
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results suggest that the cause of apoptosis may be associated with 
increase of ROS under the 100 µg/ml treatment of CHCl3-F but not 
under the 200 µg/ml treatment. 
The effect of catalase on cell viability was examined by the 
neutral red method. As shown in Fig. 7, cell viability decrease induced 
by CHCl3-F (100 µg/ml) was improved with catalase.  
 
3.4. Effect of CHCl3-F on mitochondrial membrane potential  
The increase of intracellular ROS is well known to impair a 
variety of intra- and extra-mitochondrial membrane transport system 
such as distribution of mitochondrial ion-transport system and 
decrease of mitochondrial membrane potential, which may contribute 
to apoptosis. As shown in Fig. 8, the mitochondrial membrane 
potential was declined by CHCl3-F (100-200 µg/ml) after 60 mins of 
incubation.  
The increase in ROS is also considered the cause of changes in 
mitochondrial membrane potential. Most likely, catalase contributes to 
the formation of water and molecular oxygen from hydrogen peroxide. 
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To examine whether the decline of the mitochondrial membrane 
potential is associated with ROS, we used catalase to scavenge the 
increased ROS. We then examined the relationship between the 
decline of the mitochondrial membrane potential and the increase of 
ROS. As shown in Fig. 9, the decline of mitochondrial membrane 
potential induce by CHCl3-F was not recovered by the addition of 
catalase. This result indirectly explains that the increase in ROS was 
not the cause of a decline in mitochondrial membrane potential.  
 
3.5. Effect of CHCl3-F on Rb protein 
Cell cycle analysis showed a cell cycle arrest at G1 phase by addition 
of 100 µg/ml of CHCl3-F and at the G2/M phase by the addition of 
200 µg/ml of CHCl3-F. Rb protein is a tumor suppressor protein found 
to be dysfunctional in a number of cancers. The normal function of Rb 
is to prevent the cell from dividing or progressing through the cell 
cycle. The product of the Rb gene prevents S-phase entry during the
 
cell cycle, and inactivation of this growth-suppressive function
 
is 
presumed to result from phosphorylated retinoblastoma protein (ppRb) 
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during the
 
late G1 phase and S phase, with dephosphorylation during 
the G2/M phase. Western blot analysis showed that treatment of 
CHCl3-F increased Rb levels compared with control at 8 hrs (Fig. 10).  
To determine whether the CHCl3-F induced increase in 
intracellular peroxide was associated with Rb protein, we examined the 
effect of catalase on Rb protein. As shown in Fig. 11, treatment of 
CHCl3-F increased Rb levels, however, these effects were not reversed 
by the addition of 200 units/ml catalase at 5 mins before the treatment 
of 100 µg/ml of CHCl3-F. This result suggests that the increase in ROS 
was not associated with Rb levels in CHCl3-F of Z. jujuba. 
 
3.6. Effect of CHCl3-F on p27
Kip1
 
The p27
Kip1
 is a member of the Cip/Kip family of 
cyclin-dependent kinase inhibitor. The overexpression of p27
Kip1
 
protein in mammalian cells induces G1 arrest of the cell cycle. As 
shown in Fig. 12, the p27
Kip1
 levels increased when the cells were 
treated with 100 µg/ml of CHCl3-F, but phosphorylation of p27
Kip1
 was 
observed under the treatment of 200 µg/ml of CHCl3-F.  
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To determine whether the CHCl3-F of Z. jujuba extract-induced 
increase in intracellular peroxide is associated with p27
Kip1
 protein, we 
examined the effect of catalase on p27
Kip1 
protein. As shown in Fig. 13, 
the increase of p27
Kip1
 induced by CHCl3-F could not be reversed when 
catalase was added at 5 mins before the treatment 100 µg/ml of 
CHCl3-F. This result suggests that the increase in ROS is not associated 
with p27
Kip1
 levels in CHCl3-F of -treated cells. 
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Fig. 1. Effect of Z. jujuba extract on cell viability in HepG2 cells  
Cells were cultured in Dulbecco's modified Eagle's medium containing 10% 
FBS for 3 days, diluted and incubated again in flesh medium with or without 
Z. jujuba extract. Cell viability was measured 24 hrs later by neutral red 
method. Results are representative of three separate determinations. Each 
bar is the mean (± S.D.) of three experiments. *p<0.05, **p<0.01 
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Z. jujuba extract 
 
Dissolved in water 
 
Extracted with chloroform 
     
 in vacuo     
Extracted with ethyl acetate      Chloroform fraction (CHCl3-F) 
 
                            in vacuo   
Extracted with butanol     Ethyl acetae fraction (EtOAc-F) 
 
in vacuo 
Extracted with water      Butanol fraction (BuOH-F) 
in vacuo   
Water fraction (Water-F) 
 
Fig. 2. Method of fractionation of Z. jujuba extract 
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Fig. 3. Effect of various fractions of Z. jujuba extract on cell viability in HepG2 
cells 
Cells were treated with or without various fractions of Z. jujuba extract. Cell 
viability was measured 24 hrs later by neutral red method. Each bar is the 
mean (± S.D.) of three experiments. *p<0.05, **p<0.01 
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Fig. 4. Effect of CHCl3-F of Z. jujuba extract on cell viability in HepG2 cells  
Cells were treated with or without CHCl3-F. Cell viability was measured 24 hrs 
later by neutral red method. Each bar is the mean (± S.D.) of three 
experiments. *p<0.05, **p<0.01 
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Fig. 5. Effect of CHCl3-F on cell cycle in HepG2 cells 
 Cells were incubated with CHCl3-F of Z. jujuba extract for 24 hrs, washed 
twice in PBS, and incubated with fleshly prepared PI-stained buffer for 1 hr at 
37C in dark. The staining was analyzed by laser scanning cytometer. Results 
are representative of three separate determinations. Each bar is the mean (± 
S.D.) of three experiments. *p<0.05, **p<0.01 
 
Sub-G1 G1 S G2/M
0
20
40
60
80
%
 o
f 
to
ta
l 
c
el
l
Control
100 µg/ml
200 µg/ml
**
* *
*
* *
 CHAPTER I 
 23 
 
 
 
 
Fig. 6. Effect of CHCl3-F on intracellular ROS levels in HepG2 cells  
The intracellular ROS levels were measured by the DCFH-DA method. DCF 
fluorescence intensity of cells was measured at 15, 30 and 60 mins after 
treatment with the 100 µg/ml or 200 µg/ml of CHCl3-F. Data are presented as 
means ± S.D. *p<0.05, **p<0.01 compared to the control group at the same 
time points. 
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Fig. 7. Effect of catalase on cell viability in HepG2 cells 
The cell viability was examined by the neutral red method. After 3-4 days 
culture in Dulbecco's modified Eagle's medium supplemented with 10% FBS, 
the cells were washed and cultured again in flesh medium with or without the 
CHCl3-F. Catalase (200 units/ml) was added at 5 mins before incubation of 
CHCl3-F and cell viability was measured at 24 hrs later. Each bar is the mean 
(± S.D.) of three experiments. p<0.01 
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Fig. 8. Effect of CHCl3-F on mitochondrial membrane potential in HepG2 cells  
The mitochondrial membrane potential in the cells were measured by the 
rhodamine 123 method at 30, 60, 120 and 240 mins after treatment with the 
100 µg/ml or 200 µg/ml of CHCl3-F. Data are presented as means ± S.D. 
**p<0.01 compared to the control group at the same time points. 
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Fig. 9. Effect of catalase on mitochondrial membrane potential in HepG2 cells 
The mitochondrial membrane potential in the cells in the presence of catalase 
were measured by the rhodamine 123 method at 2 hrs after treatment with the 
100 µg/ml or 200 µg/ml of CHCl3-F. Catalase (200 units/ml) was added 5 mins 
before CHCl3-F treatment. Data are presented as means ± S.D. **p<0.01 
compared to the control group at the same time points. 
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Fig. 10. Effect of CHCl3-F on Rb protein in HepG2 cells  
HepG2 cells were treated with 100 µg/ml or 200 µg/ml CHCl3-F for 8 hrs. Cell 
lysis and Western blotting were performed as described in Materials and 
Methods. Data shown are representative of at least three independent 
experiments. 
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Fig. 11. Effect of catalase on Rb protein in HepG2 cells 
Catalase (200 units/ml) was added 5 mins before treatment of 8 hrs-incubated 
HepG2 cells with 100 µg/ml CHCl3-F. Cell lysis and Western blotting were 
performed as described in Materials and Methods. Data shown are 
representative of at least three independent experiments. 
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Fig. 12. Effect of CHCl3-F on p27
Kip1
 protein in HepG2 cells  
HepG2 cells were treated with 100 µg/ml or 200 µg/ml CHCl3-F for 8 hrs. Cell 
lysis and Western blotting were performed as described in Materials and 
Methods. Data shown are representative of at least three independent 
experiments. 
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Fig. 13. Effect of catalase on p27
Kip1
 protein in HepG2 cells  
Catalase (200 units/ml) was added 5 mins before treatment of HepG2 cells 
with 100 µg/ml CHCl3-F. Cell lysis and Western blotting were performed as 
described in Materials and Methods. Data shown are representative of at least 
three independent experiments. 
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4. Discussion 
 In this chapter, we showed that the Z. jujuba extract has 
cytotoxic activities in HepG2 cells. Furthermore, the chloroform 
fraction of Z. jujuba extract (CHCl3-F) was the most effective 
component. It was not only cytotoxic but it had cytostatic activity as 
well. Also, different concentrations of CHCl3-F showed different 
growth inhibition effects in HepG2 cells. The results obtained from cell 
cycle analysis also showed that in HepG2 cells, there was a 
concentration dependent effect of CHCl3-F induced apoptosis and arrest 
of cell cycle in different phases. 
 These results differ from a previously reported study that the 
EtOAc-F of Z. jujuba had cytotoxic activities in some tumor cell lines
 
22)
. This may be due to the fact that various fractions of Z. jujuba have 
different effects in various tumor cell lines. 
 An imbalance between cell proliferation, apoptosis, and 
differentiation leads to the development of malignant cells clones. 
Based on the understanding of tumor biology in respect of the kinetics 
of cell populations, two new strategies, induction of apoptosis and 
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anti-proliferation, have recently emerged in the fields of cancer 
chemoprevention and chemotherapy by phytochemicals. Apoptosis is a 
subtype of cell death that is involved in diverse physiological and 
pathological processes. Many studies have shown that apoptosis is 
closely associated with excessive production of reactive oxygen
 
species 
(ROS)
 33, 34, 35)
. ROS include free radicals such as superoxide anion 
(O2 
・
‾), hydroxyl radicals (
・OH) and nonradical hydrogen peroxide 
(H2O2). The excessive production of ROS may damage various 
intracellular macromolecules,
 
leading to oxidative stress accompanied 
by loss of
 
cell function and possibly apoptosis and/or necrosis
 36, 37, 38)
. 
Our results showed that at low concentration of CHCl3-F there is a 
rapid elevation of the intracellular ROS level (Fig. 6). Furthermore, cell 
viability was significantly improved with the addition of catalase (Fig. 
7). These results suggest that the CHCl3-F of Z. jujuba extract induced 
apoptosis in HepG2 cells was related to the rapid increase of 
intracellular ROS, i.e., the increase in hydrogen peroxide when cells 
were treated at low CHCl3-F concentrations. Furthermore, recent 
studies have suggested that mitochondria play an important role in 
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apoptosis triggered by many stimuli such as oxidative stress and radial 
ray
 39, 40)
. The increase of ROS was probably due to the affected 
mitochondria cycling dioxygen through the electron transport assembly, 
and by generating ROS by one-electron-transfer mitochondria could be 
a main target of nonspecific damage because of oxidative stress at the 
level of the outer and inner membrane
 41)
. As a consequence of 
oxidative membrane damage, membrane potential and 
permeability-barrier function is impaired which leads to apoptosis. On 
the other hand, other studies suggested that the apoptosis of various cell 
types, such as human leukemia HL-60 cells and human leukemia K562 
cells
 42, 43, 44)
, were induced by ROS-independent mitochondrial 
dysfunction pathway. In this chapter, we also found the CHCl3-F 
decreased mitochondrial membrane potential at both low and high 
concentration in another pathway unrelated to ROS (Fig.8 and 9). Taken 
together, these results suggest that the CHCl3-F-induced apoptosis was, 
at low concentration, related to both a ROS-increase pathway and a 
ROS-independent mitochondrial dysfunction pathway, but at the higher 
concentration, apoptosis was only induced in ROS-independent 
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mitochondrial dysfunction pathway.  
Another effect of CHCl3-F observed in this chapter in HepG2 
cells was anti-proliferation. In general, anti-proliferation is usually 
expressed in cell cycle arrest. The cell cycle transitions are controlled 
by cyclin-dependent kinase (CDKs). The p27
Kip1
 is a member of 
Cip/Kip family of cyclin-dependent kinase inhibitor (CDKI). It plays 
a critical role in negative regulation of cell division in vivo. Its ability 
to enforce G1 restriction point is derived from its inhibitory binding 
to cyclin E-cdk2 and other cyclin E-cdk2 complexes
 45, 46, 47)
. p27
Kip1
 
binds to a wide variety of cyclin/CDK complexes including CDK2 
and CDK4 
 46, 48, 49)
, inhibiting kinase activity 
 50, 51)
 and blocking 
cell cycle
 52, 53, 54)
. The over expression of p27
Kip1
 protein in 
mammalian cells induces G1 arrest in cell cycle. Furthermore, in the 
case of progression from G1 to S, another apparent target is Rb 
protein. Rb is bound to the transcription factor E2F during G1 but 
upon phosphorylation, E2F is released and cell cycle progresses to S 
phase
 55)
. Many studies have reported that the accumulation of
 
p27
Kip1
 
protein inhibits CDK2 activity followed by an increase
 
in 
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hypophosphorylated levels of Rb protein. In this chapter, low 
concentration CHCl3-F of Z. jujuba extract induced the 
hypophosphorylation of Rb protein and an accumulation of p27
Kip1
 
protein when compared with the control at 8 hrs (Fig. 10 and 12). 
These results were consistent with the G1 phase arrest in cell cycle 
analysis under the treatment with low concentrations of CHCl3-F. On 
the other hand, some studies have shown that phosphorylation of 
p27
Kip1
 results in elimination of p27
Kip1
 from the cell, allowing cells 
to transit from G1 to S phase. The Rb protein was phosphorylated 
following cell cycle progress to S phase and finally dephosphorylated 
to hypophosphorylated Rb at G2/M phase. In this chapter, the high 
concentration of CHCl3-F decreased the p27
Kip1
 levels and generated 
the phosphorylation of p27
Kip1
 in HepG2 cells (Fig. 12), and the 
hypophosphorylation of Rb protein (Fig. 10) was remained. This 
result suggests that the cell cycle progressed from G1 to S phase and 
was finally arrested at G2/M phase. However, the precise mechanism 
of the G2/M phase arrest at high concentration is still unclear. 
Additional studies are needed to clarify this mechanism in HepG2 
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cells. Furthermore, other studies have reported that the increase of 
ROS levels, such as H2O2, may trigger signal transduction 
mechanisms that regulate cell
 
growth, transformation, aging, and 
apoptosis
 56, 57)
. These data suggested that apoptosis and ROS 
responses may be tied to p53-dependent regulation of cell cycle 
control and stress-activated pathways
 57)
. In contrast, our results 
showed that the increase of ROS levels were not tied to the p27
Kip1
 
protein levels and the hypophosphorylation Rb protein levels (Fig. 11 
and 13). 
On the components in Z. jujuba, Lee et al
 22)
 identified eleven 
triterpenoic acids (colubrinic acid, alphitolic acid, 
3-0-cis-p-coumaroylalphitolic acid, 3-O-trans-p-coumaroylalphitolic 
acid, 3-O-cis-p-coumaroylmaslinic acid, 
3-O-trans-p-coumaroylmaslinic acid, betulinic acid, oleanolic acid, 
betulonic acid, oleanonic acid and zizyberenalic acid) using repeated 
column chromatography of EtOAc-soluble fraction of the methanol 
extract of Z. jujuba on silica gel followed by gel filtration on Sep-Pak 
C18 cartridge and preparative HPLC. Furthermore, they showed that 
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the lupine-type triterpenes, such as 3-O-cis p- coumaroylalphitolic 
acid, 3-O-trans-p-coumaroylalphitolic acid, betulinic acid and 
betulonic acid, had high cytotoxic activities against K562, B16, 
SK-MEL-2,LOX-IMVI and A549 tumor cell lines. The main and 
effective component(s) of the CHCl3-F extract in this chapter is/are 
not clear but currently under investigation.  
An interesting finding in this chapter was the differential 
effects induced in HepG2 cells by different concentrations of Z. 
jujuba extract. Some studies have shown such phenomenon, 
including Liu et al. (2006), who demonstrated that differences of cell 
cycle arrest in human breast cancer cells were induced by different 
drug concentrations. However, the reasons for these effects are still 
not clear
 58)
.  
Our results showed that Z. jujuba extract induced apoptosis 
and different cell cycle arrests in HepG2 cells, and therefore suggest 
that Z. jujuba may play an effective contribution in the search for 
anticancer treatment for hepatoma. However, the molecular basis of 
such effects needs further investigation. 
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5. Summary 
The extract of Z. jujuba decreased the viability of the cells. 
Further extraction of the initial Z. jujuba extract with organic solvents 
revealed that the chloroform fraction (CHCl3-F) was the most 
effective. Interestingly, the CHCl3-F induced not only apoptosis but 
also G1 arrest at a low concentration (100 μg/ml) and G2/M arrest at a 
higher concentration (200 μg/ml) by cell cycle assay. Apoptosis, an 
increase in intracellular ROS level, a decline of mitochondrial 
membrane potential at low Z. jujuba concentrations, and a 
ROS-independent mitochondrial dysfunction pathway at high 
concentrations were all observed. CHCl3-F-induced G1 arrest in 
HepG2 cells was associated with an increase in hypohosphorylation of 
Rb and p27
Kip1
, and a decrease of phosphorylated Rb. However, 
CHCl3-F-induced G2/M arrest in HepG2 cells correlated with a 
decrease of the p27
Kip1
 levels and generation of the phosphorylation of 
p27
Kip1
, however the hypohosphorylation of Rb protein remained. 
Collectively, our findings suggest that the CHCl3-F extract of Z. 
jujuba extract induced a concentration dependent effect on apoptosis 
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and a differential cell cycle arrest in HepG2 cells.  
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CHAPTER II 
 
Green tea extracts enhances the selective cytotoxic activity 
of Zizyphus jujuba extracts in HepG2 cells 
 
1. Introduction 
In Chapter I, we investigated the anticancer activity of the 
chloroform fractions from Z. jujuba extract (CHCl3-F) and its 
underlining mechanisms of action in HepG2 cells, and found that the 
CHCl3-F decreased the viability of HepG2 cells. Interestingly, the 
CHCl3-F induced not only apoptosis but also G1 arrest at a low 
concentration (100 µg/ml) and G2/M arrest at a high concentration (200 
µg/ml). We also showed that CHCl3-F-induced G1 arrest in HepG2 cells 
was associated with an increase in hypophosphorylation of Rb and 
p27
Kip1
, an inhibitor of cyclin-dependent kinase, and a decrease in 
phosphorylated Rb. However, CHCl3-F-induced G2/M arrest in HepG2 
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cells correlated with a decrease in the p27
Kip1
 levels and the 
phosphorylation of p27
Kip1
, but the hypophosphorylation of Rb protein 
still remained. Our findings suggested that the CHCl3-F of Z. jujuba 
might contribute to the antineoplastic activity of HepG2 cells, and 
might become a new plant component that could prevent or be used to 
treat cancer in the future.  
Z. jujuba has various biological activities and is traditionally 
used in oriental medicines. It is also used as jujuba tea which contains Z. 
jujuba and green tea. Many people in China drink jujuba tea as opposed 
tea alone and believe that the combination of Z. jujuba with green tea 
(GTE) have synergistic effects that enhance immune function. GTE 
alone has been shown to prevent or inhibit cancer growth in vitro and in 
vivo
 59, 60)
. However, the additive or synergistic effect of combining Z. 
jujuba with the extracts of GTE on anticancer activity in vitro or in vivo 
has not been reported. 
In this Chapter, we hypothesized that the combination of Z. 
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jujuba with GTE might influence HepG2 cells, and their effects would 
be apparent in the apoptotic and cell cycle inhibition pathway. 
Therefore, we used low concentrations (100 µg/ml) of Z. jujuba extract 
in combination with GTE, and investigated their interaction in HepG2 
cells.  
 
2. Materials and Methods 
2.1. Materials  
Z. jujuba extract and GTE were kindly donated by Sea Load Co. 
Ltd. (Fukui, Japan) and Taiyo Kagaku (Japan), respectively. 2’, 7’- 
Dichlorodihydrofluorescein diacetate (DCFH-DA) was purchased from
 
Sigma–Aldrich Fine Chemical (Tokyo, Japan). Rb, p21Waf1/Cip1, p27Kip1, 
p53 and cyclin E antibodies were purchased from Santa Cruz 
Biotechnology Inc. (Santa Cruz, CA, USA). FBS was purchased from 
Equitech-Bio Inc. (Kerrville, Texas, USA). Other chemicals used in this 
study were special grade commercial products. 
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2.2. Cell culture 
HepG2 cells were cultured in Dulbecco’s modified Eagle’s 
medium supplemented with 10% FBS in a humidified incubator 
containing 5% CO2 in air at 37C for 3-4 days, then washed and 
cultured again in fresh medium at a concentration of 2.5×10
5
/ml in 35 
mm plastic dishes overnight.  
Rat hepatocytes were isolated from 10 week-old male Wistar 
rats anesthetized with diethyl ether by collagenase perfusion. The 
isolated hepatocytes were plated in 35 mm plastic dishes at a density 
of 2.5×10
5
 cells/ml in 2 ml Williams’ Medium E supplemented with 
10% FBS, and were cultured in humidified atmosphere of 5% CO2 and 
95% air at 37C overnight.  
CHCl3-F and GTE were dissolved in dimethyl sulfoxide 
(DMSO) and water respectively, then CHCl3-F and GTE were diluted 
in the culture medium immediately before use (final DMSO 
concentration < 0.125%). In all the experiments, control cultures 
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comprised the medium, DMSO and the cells.  
 
2.3. Fractionation of Z. jujuba extract   
Z. jujuba extract was diluted at 1/20 with water, and the 
mixtures were extracted with chloroform. The fractions were 
evaporated to dryness in vacuo. Finally, the powder was dissolved in 
DMSO at a concentration of 200 µg/2.5 µl.  
 
2.4. Cell viability 
Cell viability was determined with the neutral red uptake assay, 
based on the lysosomal uptake of neutral red
 23)
. Following specified 
incubations with test agents, neutral red solution
 
(0.25 mg/ml) was 
added to the cell cultures at a final concentration
 
of 50 µg/ml. After 
incubation at 37°C for 2 hrs, cells were
 
rinsed twice with a mixture of 
1% (v/v) formaldehyde, 1% (v/v) calcium chloride, and 98% (v/v) 
distilled water. Subsequently, 1 ml of destaining buffer
 
consisting of 1% 
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(v/v) acetic acid, 50% (v/v) ethanol, and 49%
 
(v/v) distilled water was 
added to the cells, and the culture
 
dishes were stood for 30 mins. 
Lysosomal
 
uptake of neutral red was determined spectrophotometrically 
at
 
540 nm. Viability was expressed as (A540-treated cells/A540
 
of 
appropriate control) ×100% after correction for background
 
absorbance 
(100% cytotoxicity)
 61)
. 
 
2.5. cell cycle assay 
Cell cycle distribution was analyzed by laser scanning cytometer 
(Olympus LSC 101) using PI staining. Briefly, after designated 
treatments, cells were washed twice in PBS and incubated with freshly 
prepared PI-stained buffer (0.1% Triton X-100 in PBS, 20 µg/ml PI, 
200 µg/ml RNase) for 1 hr at 37°C in the dark
 27)
. 
 
2.6. DNA synthesis assay 
 HepG2 cells were cultured in the presence of CHCl3-F or GTE 
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as well as bromodeoxyuridine (BrdU) (0.1 mM) for 24 hr. Cells were 
washed twice with PBS and added to a mixture of 95% ethanol and 5% 
acetic acid at 4°C for 30 mins, then washed with PBS. Subsequently, 1 
ml of formamide was added to the cells, and the culture
 
dishes were 
cultured for 1 hr at 70°C in the dark, and then washed with PBS. After 
washing with PBS 3 times for 2 mins, the culture
 
dishes were incubated 
with 1:50 dilute anti-BrdU antibody at room temperature for 1 hr, and 
then washed with PBS for 2 mins, and incubated with 1:200 diluted 
biotinylated mouse IgG for 1 hr at room temperature. The culture
 
dishes 
were washed with PBS once more for 2 mins and incubated with 1:400 
dilute horse radish peroxidase-coupled streptavidin for 1 hr at room 
temperature. After washing with PBS, the color reaction was developed 
with 3,3'-Diaminobenzidine (DAB). The number of BrdU positive 
nuclei was counted in three microscopic fields in each specimen.  
  
2.7. ROS assay 
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DCFH-DA (8 μM) was added at the last 15 mins of CHCl3-F or 
(and) GTE treatment. Cells were washed with PBS twice and 
resuspended in Hanks solution.  Fluorescence intensity was measured 
using a micro-plate reading fluoroscan plate-reader (Wallac 1420 
ArVOsx, Amersham Pharmacia Biotech) with the excitation 
wavelength at 485 nm and the emission wavelength at 535 nm. The 
amount of intracellular ROS was calculated from a standard curve 
derived from 2’, 7’ –dichlorofluorescein (DCF). Protein concentration 
was measured by the Bradford method 
 31)
.  
 
2.8. Western blot analysis of Rb, p27
Kip1
, p21
Waf1/Cip1
, p53 and cyclin E
 
Cells were harvested after 8 hrs and were washed twice in PBS. 
Then, the cells were dissolved for 30 mins with
 
lysis buffer (150 mM 
NaCl, 50 mM Tris
 
(pH 7.2), 1 mM EDTA, 0.5% sodium deoxycholate, 
1% Nonidet P-40, 1 mM sodium vanadate, 1 mM NaF, 20 µg/mL
 
aprotinin, 50 µg/ml leupeptin, 10 µg/ml
 
Pepstatin A and 100 µg/ml 
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phenylmethylsulfonyl
 
fluoride). Finally, the solution was centrifuged 
at 2000 ×g for 20 mins at 4°C. The supernatant was collected and 
protein concentrations were determined by Bradford method. Equal 
amounts of protein were fractionated on 10% SDS-PAGE gels and
 
transferred to 0.45 µm PVDF
 
(Hybond; Amersham Pharmacia 
Biotech). Efficiency of transfer and equal loading of protein were 
confirmed by staining membranes with Coomassie Brilliant blue 
(0.1%) in 5% acetic acid. After overnight blocking in 0.1% Tween-20
 
and 5% non-fat dry milk in PBS, the blots were incubated with the 
respective antibodies for 1 hr at room temperature. The antibodies 
included anti-Rb, anti- p21
Waf1/Cip1
, anti- p27
Kip1
, anti-p53 and 
anti-cyclin E. After washing, the membrane was reincubated with 
1:750 diluted biotinylated mouse IgG or rabbit IgG for 1 hr at room 
temperature. The membrane was washed several times, and incubated 
with 1:750 diluted horse radish peroxidase-coupled streptavidin for 1 
hr at room temperature. After several washing steps, the color reaction 
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was developed with DAB. Densitometry analysis of the protein bands 
was performed with the software Scion Image.  
 
2.9. Statistical analysis  
Data are represented as means ± S.D (standard deviation from 
the mean). The significance of difference in assay values was 
evaluated with ANOVA followed by Dunnett’s multiple comparison 
post hoc tests. A p value of less than 0.05 was considered significant. 
The observed interaction was confirmed by isobolographic analysis of 
data derived from the neutral red uptake assay analysis at 24 h. 
 
3. Results 
3.1. Effect of GTE on cell viability in HepG2 cells 
 To determine the adequate concentration of GTE, we examined 
the effect of GTE with different concentrations in HepG2 cells on cell 
viability. As shown in Fig. 1, cell viability decreased with 60 µg/ml, 
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but not with 30 µg/ml of GTE. Therefore, we used 30 µg/ml of GTE 
for subsequent experiments as this concentration of GTE that did not 
affect cell viability. 
 
3.2. Effect of CHCl3-F and GTE on cell viability in HepG2 cells 
To investigate whether the combination of CHCl3-F with GTE 
induces cytotoxicity in HepG2 cells, we examined the cell viability by 
neutral red method. As shown in Fig. 2, cell viability was decreased in 
the presence of CHCl3-F and GTE.  
 
3.3. Effect of CHCl3-F and GTE on cell viability in rat hepatocytes 
To investigate the effect of CHCl3-F and GTE in normal cell 
lines, we examined the effect of CHCl3-F and GTE on cell viability in 
rat hepatocytes. As shown in Fig. 3, no effect on cell viability was 
observed in rat hepatocytes after treatment of CHCl3-F and/or GTE.  
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3.4. Effect of CHCl3-F and GTE on intracellular ROS levels  
We have shown that the intracellular ROS level increased 
rapidly when cells were incubated with 100 µg/ml of CHCl3-F, and that 
the increase in ROS was associated with apoptosis. Therefore, we 
examined the effects of CHCl3-F and GTE on intracellular ROS levels 
to see whether ROS is related to the enhanced cytotoxicity with 
CHCl3-F and GTE. There was no enhanced effect on ROS levels when 
cells were treated with both CHCl3-F and GTE (Fig. 4).  
 
3.5. Effect of CHCl3-F and GTE on cell cycle in HepG2 cells  
We examined the effect of CHCl3-F and GTE on cell cycle in 
HepG2 cells. As shown in Fig. 5, significant increase in G1, but not in 
sub-G1 cell cycle region, was observed when cells were treated with 
the combined CHCl3-F and GTE.  
 
3.6. Effect of CHCl3-F and GTE on DNA synthesis in HepG2 cells 
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 To confirm the G1 arrest by the combination of CHCl3-F and 
GTE, we investigated the effect on the DNA synthesis with the 
treatment of CHCl3-F and GTE in HepG2 cells. As shown in Fig. 6, an 
enhanced effect on DNA synthesis was observed.  
 
3.7. Effect of CHCl3-F and GTE on Rb protein in HepG2 cells 
To investigate the mechanism of G1 arrest in CHCl3-F and 
GTE-treated in HepG2 cells, we examined Rb protein, which acts as a 
tumor suppressor by providing a cell cycle checkpoint between the G1 
and S phase. As shown in Fig. 7, the treatment with CHCl3-F and GTE 
decreased hypophosphorylation Rb protein levels and increased the 
phosphorylation of Rb protein levels after 8 hrs of culture. This result 
suggests that the enhanced inhibition of cell cycle arrest is caused by 
the suppression of phosphorylation of Rb protein. 
 
3.8. Effect of CHCl3-F and GTE on p27
Kip1
 in HepG2 cells  
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In an earlier study we showed that p27
Kip1
 protein increased in 
cells incubated with 100 µg/ml of CHCl3-F. Hypophosphorylated Rb 
was induced, followed by an arrest at the G1 cell cycle phase. Therefore, 
we examined the effect of the combination of CHCl3-F and GTE on the 
status of the phosphorylation of p27
Kip1
. As shown in Fig. 8, the p27
Kip1
 
levels decreased when the cells were treated with CHCl3-F and GTE for 
8 hrs.  
 
3.9. Effect of CHCl3-F and GTE on p21
Waf1/Cip1
 in HepG2 cells 
To investigate the cause of cell cycle arrest by CHCl3-F and 
GTE in HepG2 cells, we measured the p21
Waf1/Cip1
protein, another 
protein associated with the phosphorylation of Rb in G1 phase. As 
shown in Fig. 9, the p21
Waf1/Cip1
 protein levels increased when the cells 
were treated with CHCl3-F and GTE for 8 hrs. 
 
3.10. Effect of CHCl3-F and GTE on p53 in HepG2 cells 
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To investigate the up-stream regulation of p21
Waf1/Cip1
 protein, 
we measured p53 protein, a tumor suppressor protein associated with 
the expression of p21
Waf1/Cip1
. As shown in Fig. 10, p53 protein levels 
increased after the cells were treated with CHCl3-F and GTE for 8 hrs. 
 
3.11. Effect of CHCl3-F and GTE on cyclin E in HepG2 cells 
Cyclin E is another checkpoint protein in G1 cell cycle phase 
arrest. To investigate the changes in cyclin E, cells were treated with 
CHCl3-F and GTE in HepG2 cells for 8 hrs. As shown in Fig. 11, the 
cyclin E levels decreased with the treatment of GTE alone or the 
combination of CHCl3-F and GTE. 
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Fig. 1. Effect of GTE on cell viability in HepG2 cells  
Cells were cultured in Dulbecco's modified Eagle's medium with or without 
various concentration of GTE. Cell viability was measured 24 hrs later by 
neutral red method as described in Materials and Methods. Results are 
representative of three separate determinations. Each bar is the mean (± 
S.D.) of three experiments. *p<0.05. 
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Fig. 2. Effect of CHCl3-F and GTE on cell viability in HepG2 cells 
Cells were cultured in Dulbecco's modified Eagle's medium with or without 
CHCl3-F and GTE (30 µg/ml). Cell viability was measured 24 hrs later by 
neutral red method. Results are representative of three separate 
determinations. Each bar is the mean (± S.D.) of three experiments. Data not 
sharing common alphabet are significantly different (p<0.01). 
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Fig. 3. Effect of CHCl3-F and GTE on viability of rat hepatocytes 
The isolated hepatocytes were cultured in Williams’ Medium E with or 
without CHCl3-F and GTE (30 µg/ml). Cell viability was measured 24 hrs 
later by neutral red method as described in Materials and Methods. Results 
are representative of three separate determinations. Each bar is the mean (± 
S.D.) from three experiments. 
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Fig. 4. Effect of CHCl3-F and GTE on intracellular ROS levels in HepG2 cells  
The intracellular ROS levels were measured by the DCFH-DA method. DCF 
fluorescence intensity of cells was measured at 15, 30 and 60 mins after 
treatment with GTE, CHCl3-F, or CHCl3-F and GTE. Data are presented as 
means ± S.D. **p<0.01 compared to the control group at the same time points. 
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Fig. 5. Effect of CHCl3-F and GTE on cell cycle in HepG2 cells 
 Cells were incubated with GTE, CHCl3-F, or CHCl3-F and GTE for 24 hrs, 
washed twice in PBS, and incubated with prepared PI-stained buffer for 1 hr 
at 37C in dark. The stained cells were analyzed by laser scanning cytometer. 
Results are representative of three separate determinations. Each bar is the 
mean (± S.D.) of three experiments. *p<0.05, **p<0.01 
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Fig. 6. Effect of CHCl3-F and GTE on DNA synthesis in HepG2 cells 
Cells were incubated with GTE, CHCl3-F, or CHCl3-F and GTE for 24 hrs. 
DNA synthesis was measured by the percentage of BrdU positive cells. 
Results are representative of three separate determinations. Each bar is the 
mean (± S.D.) of three experiments. Data not sharing common alphabet are 
significantly different (p<0.01). 
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Fig. 7. Effect of CHCl3-F and GTE on Rb protein in HepG2 cells  
Cells were incubated with GTE, CHCl3-F, or CHCl3-F and GTE for 8 hrs. Cell 
lysis and Western blotting were performed as described in Materials and 
Methods. Data shown are representative of at least three independent 
experiments.  
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Fig. 8. Effect of CHCl3-F and GTE on p27
Kip1
 protein in HepG2 cells  
Cells were incubated with GTE, CHCl3-F, or CHCl3-F and GTE for 8 hrs. Cell 
lysis and Western blotting were performed as described in Materials and 
Methods. Data shown are representative of at least three independent 
experiments.  
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Fig. 9. Effect of CHCl3-F and GTE on p21
Waf1/Cip1
protein in HepG2 cells  
Cells were incubated with GTE, CHCl3-F, or CHCl3-F and GTE for 8 hrs. Cell 
lysis and Western blotting were performed as described in Materials and 
Methods. Data shown are representative of at least three independent 
experiments.  
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Fig. 10. Effect of CHCl3-F and GTE on p53 protein in HepG2 cells  
Cells were incubated with GTE, CHCl3-F, or CHCl3-F and GTE for 8 hrs. Cell 
lysis and Western blotting were performed as described in Materials and 
Methods. Data shown are representative of at least three independent 
experiments.  
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Fig. 11. Effect of CHCl3-F and GTE on cyclin E in HepG2 cells  
Cells were incubated with GTE, CHCl3-F, or CHCl3-F and GTE for 8 hrs. Cell 
lysis and Western blotting were performed as described in Materials and 
Methods. Data shown are representative of at least three independent 
experiments.  
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Fig. 12. Proposed mechanism of action of CHCl3-F alone and CHCl3-F with 
GTE on G1 arrest in HepG2 cells 
                
 CHAPTER II 
 67 
4. Discussion 
 The results obtained in this chapter demonstrate for the first time, 
to the best of our knowledge, that GTE enhances the cytotoxic activity 
of CHCl3-F in HepG2 cells. The cytotoxic activity of CHCl3-F was 
enhanced after combining with low concentrations of GTE which 
initially had no affect on HepG2 cell viability. Furthermore, in rat 
hepatocytes used as a normal cell line, there was no effect on cell 
viability when the cells were treated with CHCl3-F, GTE or the 
combination of CHCl3-F and GTE. Our findings show that combining 
CHCl3-F and GTE can enhance their individual neoplastic toxicity, 
providing a new approach to the design of chemotherapy strategies.  
In chapter I, we have shown that the CHCl3-F of Z. jujuba 
extract produced ROS resulting in apoptosis in HepG2 cells. Therefore, 
we hypothesized that a possible synergistic decrease in cell viability, 
by combining CHCl3-F of Z. jujuba extract with GTE, could be the 
result of the production of ROS levels. However, we showed that 
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combining CHCl3-F and GTE did not affect ROS levels (Fig. 3), nor 
increase apoptosis in HepG2 cells. We also have shown that CHCl3-F 
induced not only apoptosis but also cell cycle arrest at the G1 phase in 
HepG2 cells. The present results show an enhanced effect in G1 arrest 
and a decrease in DNA synthesis when cells were treated with 
CHCl3-F and GTE (Fig. 5 and 6), suggesting that the cytotoxic 
activities with the combined CHCl3-F and GTE were related to growth 
inhibition but not to apoptosis.  
Uncontrolled cell proliferation is the hallmark of cancer, and 
tumor cells have acquired damage to genes that directly regulate their 
cell cycles. In the cell cycle, the period from late G1 to the S phase is 
the most important for cell proliferation. The cell cycle progression 
from G1 to S-phase requires phosphorylation of the retinoblastoma 
tumor suppressor protein, Rb, a member of the pocket protein family 
and one of the checkpoint of G1 arrest, by the cyclin D1-cdk4/6 and 
cyclin E-cdk2 complexes
 62)
. Phosphorylation of Rb in early G1 by 
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cyclin D1/cdk4/6 triggers a cascade of events that begins with the 
dissociation of E2F from Rb and the activation of transcription of 
cyclin E by E2F, and culminates with the stimulation by E2F of its 
own transcription and assembly of cyclin E with its catalytic partner 
Cdk2. The cyclin E-cdk2 complexes promote further phosphorylation 
of Rb and the release of E2F, thus establishing a positive feedback 
loop that accelerates the irreversible progression through late G1
 63)
. 
To prevent unrestrained proliferation, there are a number of 
cyclin-dependent kinase inhibitors (CDKIs) which bind with specific 
Cdks, preventing the Cdks from binding to cyclin and hence blocking 
a cascade of events which ultimately lead to cell proliferation. 
p21
Waf1/Cip1
 and p27
Kip1
 belong to the family of CDKIs
 64)
, whose 
expression regulates the G1 phase Cdks
 63)
. We have shown that 
CHCl3-F- induced G1 arrest in HepG2 cells was associated with an 
increase in hypophosphorylation of Rb and a decrease of 
phosphorylated Rb, and these changes depended on the up-regulation 
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of p27
Kip1
 protein. Therefore, we hypothesized that the effect of 
combining CHCl3-F of Z. jujuba extract with GTE was also associated 
with an up-regulation of p27
Kip1
 protein and induced 
hypophosphorylation of Rb. However, our results showed that the 
hypophosphorylation of Rb did not cause any up-regulation of p27Kip1 
protein but up-regulation of p21
Waf1/Cip1 protein instead in the presence 
of CHCl3-F and GTE (Fig. 8 and 9).  
The tumor suppressor protein p53 is also the major mediator of 
the checkpoint-induced arrest in the G1 phase of the cell cycle
 65)
. A 
variety of cellular stresses including DNA damage, hypoxia, 
nucleotide depletion, viral infection, and cytokine-activated signaling 
pathways transiently stabilize the p53 protein, causing it to accumulate 
in the nucleus, and activating it as a transcription factor
 66)
. p53 
induces cell cycle arrest, through the Cdk inhibitor p21
Waf1/Cip1 21)
, 
preventing the replication of damaged DNA. p21
Waf1/Cip1
 interacts with 
different cyclin/Cdk complexes and other regulators of transcription 
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and signal transduction, exerting broad effects on cell survival, gene 
expression and morphology
 67)
. p21
Waf1/Cip1
 effects are partially 
mediated by Rb, which is inactivated in proliferating cells through 
phosphorylation by Cdk2 and Cdk4/6, both of which are inhibited by 
p21
Waf1/Cip1
. As a result, p21
Waf1/Cip1
 induction leads to Rb 
dephosphorylation and activation, with ensuing G1 arrest
 68)
. Our 
results suggested that in the presence of the CHCl3-F and GTE, p53 
protein levels were increased and induced the Cdk inhibitor 
p21
Waf1/Cip1
 (Fig. 9 and 10), Rb dephosphorylation and activation. 
Finally, as a result, there was a G1 phase cell cycle arrest (Fig. 8). 
However, for CHCl3-F alone, only the p27
Kip1
 protein levels were 
increased, but not p53 protein or the p21
Waf1/Cip1
 protein.  
Cyclin E, whose catalytic partner is Cdk2, is another 
rate-limiting regulator of the G1phase of the cell cycle, and increased 
expression of cyclin E has been found in several types of tumors
 69)
. 
Some studies suggested that decreasing cyclin E level induced the cell 
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cycle arrest at G1 phase
 70, 71)
. In this chapter, the treatment of CHCl3-F 
alone did not decrease the expression of cyclin E levels. However, 
treatment with GTE alone or combination of CHCl3-F and GTE 
decreased the expression of cyclin E levels (Fig. 11), but the 
concentration of 30 µg/ml of GTE had no effect on the p53 level and 
the cell viability in HepG2 cells. These results suggested that both the 
increase in p53 and p21
Waf1/Cip1
 levels and the decrease in cyclin E 
levels were related to the effect of combination of CHCl3-F and GTE 
on G1 arrest.  
GTE contains a variety of polyphenols, the most important 
class of polyphenols called catechins. The major catechins found in 
GTE are called epicatechin (EC), epicatechin-3-gallate (ECG), 
epigallocatechin (EGC), and epigallocatechin-3-gallate (EGCG). Of 
these four catechins, EGCG is the most abundant and has been shown 
to be the most important cancer inhibiting chemical found in GTE
 60, 
72)
. It has been reported that the combination of green tea polyphenols 
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and grape polyphenols had synergistic anticancer effects in HeLa cells, 
and that the polyphenolic mixture was more effective than those from 
the individual sources
 73)
. Suganuma et al. reported that whole green 
tea is a more reasonable mixture of tea polyphenols for cancer 
prevention in humans than EGCG alone and that it is even more 
effective when it is used in combination with other cancer preventives
 
74)
. We examined the effects of these four catechins alone or the 
interaction between these four catechins in combination with Z. jujuba. 
However, there was no effective interaction in HepG2 (data not 
shown). Hence, we suggest that the active components in GTE are not 
the individual catechins.  
Collectively, we have found that GTE enhances the cytotoxic 
effect of CHCl3-F in HepG2 cells causing cell growth inhibition, and 
the involved mechanisms may be via two pathways. One pathway 
involved increased p53 and p21
Waf1/Cip1
 proteins. The increased 
p21
Waf1/Cip1
 bound with Cdk2 and prevented the Cdk2 from binding to 
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cyclinE, resulting in a G1 phase arrest. Also, decreasing the cyclin E 
levels directly might have led to a decrease in the cyclin E-cdk2 
complex levels and caused G1 arrest (Fig. 12). Based on these 
findings, we suggest that the combination of CHCl3-F and GTE is 
more effective than the CHCl3-F alone in the growth inhibition of 
HepG2 cells and the mechanisms of G1 arrest by CHCl3-F and GTE 
are different from that with the treatment of CHCl3-F alone. 
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5. Summary 
GTE enhanced the effect of CHCl3-F on cell viability in HepG2 
cells, without cytotoxicity in rat hepatocytes, which was used as a 
normal cell model. Furthermore, combination of CHCl3-F and GTE 
caused an effect on G1 phase arrest but not on apoptosis. Interestingly, 
the mechanism of the G1 arrest was associated, not with an increase in 
p27
Kip1
 levels and the hypophosphorylation of Rb, which are pathways 
by CHCl3-F on G1 arrest in HepG2 cells, but with increases in p53 and 
p21
Waf1/Cip1
 levels, and a decrease in cyclin E levels. Our findings 
suggest that combining CHCl3-F and GTE produces an enhanced cell 
growth inhibition effect, and that the resultant G1 arrest was caused via 
a different mechanism as that of CHCl3-F treatment alone.  
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CHAPTER III 
 
Combination of Zizyphus jujuba and green tea extracts 
exert excellent cytotoxic activity in HepG2 cells via 
reducing the expression of APRIL 
 
1. Introduction  
Cytokines regulate cellular proliferation and differentiation by 
binding to their specific receptors on target cells. Tumor necrosis 
factor (TNF) is the prototypic member of a family of cytokines 
playing an important role in immune regulation and cancer. A 
proliferation-inducing ligand (APRIL), a novel member of the TNF 
family, is reported to stimulate tumor cell growth via signaling in an 
autocrine and/or paracrine mode
 75)
. The expressions of APRIL mRNA 
and protein were high in various tumor cell lines and tissues, but 
almost undetectable in various normal tissues
 76)
. It is possible that 
APRIL may play a role in tumorigenesis. Furthermore, it has been 
demonstrated that the expression of APRIL protein was detected in 
 CHAPTER III 
 77 
human hepatocellular carcinoma cell, where it can promote 
neovascularization, as estimated by the human umbilical vein 
endothelial cell tube formation
 77)
. We have shown that combining 
CHCl3-F and GTE caused an effect on G1 phase arrest but not on 
apoptosis. Interestingly, the mechanism of the G1 arrest is associated, 
not with an increase in p27
Kip1
 levels and the hypophosphorylation of 
Rb, which are pathways of CHCl3-F on G1 arrest in HepG2 cells, but 
with increases in p53 and p21
Waf1/Cip1
 levels, and a decrease in cyclin E 
levels. However, how these factors are induced in HepG2 cells is still 
unclear. 
Knowledge of the molecular mechanisms governing malignant 
transformation brings new opportunities for therapeutic intervention 
against cancer using novel approaches. Therefore, in order to 
demonstrate the particular molecular mechanisms of the growth 
inhibitory effects of CHCl3-F and GTE mixture in HepG2 cells, 
especially elucidate the relationship between APRIL and growth 
related factors such as p27
Kip1
, p53 and p21
Waf1/Cip1
, we examined the 
time-dependent expression of APRIL, p27
Kip1
, p53 and p21
Waf1/Cip1
 by 
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combination CHCl3-F with GTE in HepG2 cells. The 
chemotherapeutic potential of treatment of hepatocellular carcinoma 
with combining CHCl3-F and GTE is discussed below.  
 
2. Materials and Methods 
2.1. Materials  
APRIL antibody was purchased from ψProSci. Inc. (Poway, 
CA, USA). p27
Kip1
, p53 and p21
Waf1/Cip1
 antibodies were purchased 
from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Other 
chemicals used in this study were special grade commercial products. 
 
2.2. Cell culture 
HepG2 cells were cultured in Dulbecco’s modified Eagle’s 
medium (DMEM) supplemented with 10% FBS in a humidified 
incubator containing 5% CO2 in air at 37C for 3-4 days, then washed 
and cultured again in fresh medium at a concentration of 2.5×10
5
/ml in 
35 mm plastic dishes overnight.  
Rat hepatocytes were isolated from 10 week-old male Wistar 
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rats anesthetized with diethyl ether by collagenase perfusion. The 
isolated hepatocytes were plated in 35 mm plastic dishes at a density 
of 2.5×10
5
 cells/ml in 2 ml Williams’ Medium E supplemented with 
10% FBS, and were cultured in humidified atmosphere of 5% CO2 and 
95% air at 37C overnight.  
CHCl3-F and GTE were dissolved in DMSO and water 
respectively. These were then diluted in the culture medium 
immediately before use (final DMSO concentration < 0.125%). Final 
concentration of CHCl3-F and GTE were 100 µg/ml and 30 µg/ml, 
respectively. In all the experiments, control cultures comprised the 
medium, DMSO and the cells.  
 
2.3. Fractionation of Z. jujuba extract   
Z. jujuba extract was diluted at 1/20 with water, and the 
mixtures were extracted with chloroform. The fractions were 
evaporated to dryness in vacuo. Finally, the powder was dissolved in 
DMSO at a concentration of 200 µg/2.5 µl.  
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2.4. Western blot analysis of APRIL, p27
Kip1
, p53 and p21
Waf1/Cip1 
Cells were harvested after 1, 2, 4 and 8 hrs and were washed 
twice in PBS. Then, the cells were dissolved for 30 mins with lysis 
buffer (150 mM NaCl, 50 mM Tris
 
(pH 7.2), 1 mM EDTA, 0.5% 
sodium deoxycholate, 1% Nonidet P-40, 1 mM sodium vanadate, 1 
mM NaF, 20 µg/mL
 
aprotinin, 50 µg/ml leupeptin, 10 µg/ml
 
Pepstatin 
A and 100 µg/ml phenylmethylsulfonyl
 
fluoride). Finally, the solution 
was centrifuged at 2000 ×g for 20 mins at 4°C. The supernatant was 
collected and protein concentrations were determined by Bradford 
method. Equal amounts of protein were fractionated on 10% 
SDS-PAGE gels and
 
transferred to 0.45 µm PVDF
 
(Hybond; 
Amersham Pharmacia Biotech). Efficiency of transfer and equal 
loading of protein were confirmed by staining membranes with 
Coomassie Brilliant blue (0.1%) in 5% acetic acid. After overnight 
blocking in 0.1% Tween-20
 
and 5% non-fat dry milk in PBS, the blots 
were incubated with the respective antibodies for 1 hour at room 
temperature. The antibodies included anti-APRIL, anti-p27
Kip1
, 
anti-p53 and anti- p21
Waf1/Cip1
. After washing, the membrane was 
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reincubated with 1:750 diluted biotinylated mouse IgG or rabbit IgG 
for 1 hour at room temperature. The membrane was washed several 
times, and incubated with 1:750 diluted horse radish 
peroxidase-coupled streptavidin for 1 hour at room temperature. After 
several washing steps, the color reaction was developed with DAB. 
Densitometry analysis of the protein bands was performed with the 
software Scion Image (Scion Corporation).  
 
2.5. Cell viability  
Cell viability was determined with the neutral red uptake assay, 
based on the lysosomal uptake of neutral red
 23)
. Following specified 
incubations with test agents, neutral red solution
 
(0.25 mg/ml) was 
added to the cell cultures at a final concentration
 
of 50 µg/ml. After 
incubation at 37°C for 2 hrs, cells were
 
rinsed twice with a mixture of 
1% (v/v) formaldehyde, 1% (v/v) calcium chloride, and 98% (v/v) 
distilled water. Subsequently, 1 ml of destaining buffer
 
consisting of 1% 
(v/v) acetic acid, 50% (v/v) ethanol, and 49%
 
(v/v) distilled water was 
added to the cells, and the culture
 
dishes were left for 30 mins. 
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Lysosomal
 
uptake of neutral red was determined spectrophotometrically 
at
 
540 nm. Viability was expressed as (A540-treated cells/A540
 
of 
appropriate control) ×100% after correction for background
 
absorbance 
(100% cytotoxicity)
 61)
. 
 
2.6. Cell cycle assay 
Cell cycle distribution was analyzed by laser scanning cytometer 
(Olympus LSC 101) using PI staining. Briefly, after designated 
treatments, cells were washed twice in PBS and incubated with freshly 
prepared PI-stained buffer (0.1% Triton X-100 in PBS, 20 µg/ml PI, 
200 µg/ml RNase) for 1 hour at 37°C in the dark. 
 
2.7. Statistical analysis  
Data are represented as means ± S.D (standard deviation from 
the mean). The significance of difference in assay values was 
evaluated with ANOVA followed by Dunnett’s multiple comparison 
post hoc tests. A p value of less than 0.05 was considered significant.  
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3. Results 
3.1. Effect of CHCl3-F and GTE on the expression of APRIL in HepG2 
cells 
To investigate whether the combination of CHCl3-F with GTE 
induce APRIL in HepG2 cells, we examined the time-dependent 
expression of APRIL. HepG2 cells were cultured with or without GTE, 
CHCl3-F or both together, for 1, 2, 4 and 8 hrs and the expression levels 
of APRIL were examined by Western blot analysis. As shown in Fig. 1, 
APRIL was expressed in HepG2 cells after 4 hrs of the incubation, and 
the addition of the mixture of CHCl3-F and GTE, but not the addition of 
CHCl3-F alone, reduced the expression levels of APRIL from 4 hrs of 
the incubation. 
 
3.2. Effect of CHCl3-F and GTE on cell viability after incubation for 
various times in HepG2 cells 
APRIL was expressed in HepG2 cells after incubation for 4 hrs. 
To investigate whether APRIL is involved in cell proliferation in 
HepG2 cells, and whether the effect of anticancer activity of 
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combining CHCl3-F with GTE or CHCl3-F alone is involved in the 
expression of APRIL, CHCl3-F or CHCl3-F with GTE were added to 
HepG2 cell culture after 0, 1, 2, 4 and 8 hrs of the incubation, and cell 
viability was examined after incubation for 24 hrs. As shown in Fig. 2, 
CHCl3-F decreased cell viability at all the indicated times. However, 
the addition of the CHCl3-F and GTE mixture did not decrease cell 
viability after 8 hrs of the incubation. It shows that the addition of 
CHCl3-F and GTE mixture to the APRIL expressed cells did not 
decrease cell viability.  
 
3.3. Effect of CHCl3-F and GTE on cell cycle after various hours of 
incubation in HepG2 cells 
To further investigate whether APRIL is involved in cell 
proliferation in HepG2 cells, and whether the effect of G1 arrest by 
CHCl3-F and GTE mixture or CHCl3-F alone is involved in the 
expression of APRIL, we examined the changes in cell cycle dynamics. 
GTE, CHCl3-F or CHCl3-F with GTE was added to HepG2 cell cultures 
after 0 and 8 hrs of incubation. At the end of 24-hrs incubation, the cell 
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cycle distribution was analyzed. As shown in Fig. 3, the addition of 
CHCl3-F alone increased the cell numbers in the G1 cell cycle region, 
and the addition of CHCl3-F and GTE mixture caused a further increase. 
However, G1 arrest was not induced in HepG2 cells incubated 8 hrs 
before the addition of combined CHCl3-F and GTE.  
 
3.4. Effect of CHCl3-F and GTE on p27
Kip1
, p53 and p21
Waf1/Cip1
 in 
HepG2 cells  
We showed in a previous study that the mechanism of G1 
arrest was associated with an increase in p27
Kip1
 levels at 8 hrs of 
incubation with CHCl3-F alone, and with an increase in p53 and 
p21
Waf1/Cip1
 levels at 8 hrs of incubation with combination CHCl3-F with 
GTE. To investigate whether APRIL is associated with these factors 
which control cell cycle progression in G1 phases, we examined the 
time-dependent expression of p27
Kip1
, p53 and p21
Waf1/Cip1
 by Western 
blotting. As shown in Fig. 4, the p27
Kip1
 levels were increased only by 
CHCl3-F alone after 2 hrs of the incubation. Only the CHCl3-F and 
GTE mixture increased p53 levels significantly at 4 hrs of incubation, 
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and p21
Waf1/Cip1 
levels at 8 hrs of incubation. 
  
3.5. Selective Inhibition of CHCl3-F and GTE Mixture 
To demonstrate the selective inhibition of the CHCl3-F and 
GTE mixture, we examined the effect of the mixture in rat hepatocytes, 
as a normal cell model, and in HepG2 cells. As shown in Table 1, the 
combination of CHCl3-F with GTE did not affect cell viability in rat 
hepatocytes, but in HepG2 cells.  
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Fig. 1. Effect of CHCl3-F and GTE on the expression of APRIL in HepG2 cells 
Cells were incubated with or without GTE, CHCl3-F, or CHCl3-F and GTE 
mixture for 0, 1, 2, 4 and 8 hrs. Cell lysis and Western blotting were performed 
as described in Materials and Methods. Inner graphs represent the 
densitometric values quantified by densitometer. Data shown are 
representative of at least three independent experiments.  
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Fig. 2. Effect of CHCl3-F and GTE on cell viability after incubation for 
various times in HepG2 cells 
GTE, CHCl3-F or CHCl3-F and GTE mixture were added to HepG2 cells 
culture after 0, 1, 2, 4 and 8 hrs of the incubation, and cell viability examined 
at the end of incubation for 24 hrs by neutral red method. Results are 
representative of three separate determinations. Each bar is the mean (± S.D.) 
of three experiments compared with control (**p<0.01). 
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Fig. 3. Effect of CHCl3-F and GTE on cell cycle after incubation for various 
times in HepG2 cells 
GTE, CHCl3-F or CHCl3-F and GTE mixture were added to HepG2 cells 
cultured for 0 and 8 hrs. After 24 hrs of the incubation, the cells were collected 
as described in Materials and Methods. Cell cycle distribution was analyzed 
by laser scanning cytometer. Results are representative of three separate 
determinations. Data not sharing common alphabet are significantly different 
(p<0.05).  
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Fig. 4. Effect of CHCl3-F and GTE on p27
Kip1
 and p53 in HepG2 cells  
The cells were treated with or without GTE, CHCl3-F or CHCl3-F and GTE 
mixture for 1, 2, 4 and 8 hrs, and cell lysis and Western blotting were 
performed as described in Materials and Methods. Inner graphs represent the 
densitometic values quantified by densitometer. Data shown are representative 
of at least three independent experiments.  
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Table 1. Selective inhibition of combined CHCl3-F and GTE on cell viability 
           
  Rat hepatocytes HepG2 cells  
    (% of control) (% of control) 
Control 100.0±2.01 100.0±0.32 
CHCl3-F+GTE  97.8±3.08  60.3±1.27** 
Values are means ± S. D. (n = 4). **P < 0.01 
 
CHCl3-F and GTE mixture were added to rat hepatocytes and HepG2 cells. 
Cell viability was measured 24 hrs later by neutral red method as described 
in Materials and Methods.  
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4. Discussion 
 We showed that the APRIL was expressed in HepG2 cells after 
4 hrs of incubation in vitro. Furthermore, addition of a mixture of 
CHCl3-F and GTE, but not CHCl3-F alone, reduced the expression of 
APRIL in HepG2 cells (Fig. 1). Our results also showed that HepG2 
cell viability was decreased in the presence of the mixture of CHCl3-F 
and GTE or CHCl3-F alone. However, CHCl3-F and GTE mixture did 
not decrease cell viability after 8 hrs of incubation (Fig. 2). 
Furthermore, the CHCl3-F and GTE mixture or CHCl3-F alone caused 
a G1 arrest, with CHCl3-F and GTE mixture having a stronger effect 
than that of CHCl3-F alone. Addition of CHCl3-F and GTE mixture to 
the 8 hrs incubation HepG2 cells did not induce an arrest of G1 phase 
(Fig. 3).  
A previous study showed that Blumea balsamifera, a medicinal 
plant, decreased cell viability via reducing the expression of APRIL in 
HepG2 cells
 78)
. When CHCl3-F was added at 8 hrs, the decrease in 
cell viability was maintained. Theses results suggest that APRIL may 
be playing an important role in cell proliferation but there may be 
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other factors also involved in cell proliferation in HepG2 cells.  
APRIL is practically undetectable in normal tissues. However, 
it is strongly up-regulated in many tumor cells in vivo and in vitro and 
stimulates tumor cell growth
 76)
. APRIL can be produced by tumor 
cells and thus can act in an autocrine manner, or by accessory cells to 
act in a paracrine manner. APRIL can induce both cell proliferation
 75, 
76, 79)
 and death
 80)
 of malignant tumors. Some studies have shown that 
the mechanism of cell death could be caused by activated NF-κB and 
c-jun N-terminal kinase (JNK), or down-regulated Bcl-2 and Bcl-xL 
and up-regulated Bax in lymphoid malignancies
 81)
. APRIL was also 
found to up-regulate c-Myc (an inducer of cell proliferation), to 
down-regulate p53 and to increase Bcl-6, an inhibitor of B-cell 
differentiation
 82)
. Although APRIL is an important ligand of cell 
proliferation in lymphoid malignancies, not many studies have shown 
its mechanism in solid tumor cells, especially in HepG2 cells. Okano 
et al. suggested that APRIL induced proliferation in hepatocellular 
carcinoma, and functional expression of APRIL might contribute to 
neovascularization via upregulation of Vascular endothelial growth 
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factor (VEGF) in hepatocellular carcinoma
 77)
. However, the 
mechanism of inducing cell proliferation is still unclear. The 
relationship between APRIL and downstream signaling of cell cycle 
regulating factors have not been described thus far.  
p21
Waf1/Cip1
 and p27
Kip1
 belong to the family of CDKIs 
(cyclin-dependent kinase inhibitors)
 64)
, whose expression regulates 
the G1 phase Cdks (cyclin-dependent kinase) in the cell cycle
 63)
. 
Furthermore, the tumor suppressor protein p53 is also the major 
mediator of the checkpoint-induced arrest in the G1 phase of the cell 
cycle
 65)
. p53 induces cell cycle arrest, through the Cdk inhibitor 
p21
Waf1/Cip1 21)
, preventing the replication of damaged DNA. p21
Waf1/Cip1
 
interacts with different cyclin/Cdk complexes and other regulators of 
transcription and signal transduction, exerting broad effects on cell 
survival, gene expression and morphology
 67)
. We have shown that in 
HepG2 cells, the induction G1 phase arrest was via p27
Kip1
 pathway 
with the addition of CHCl3-F alone, but via p53 and p21
Waf1/Cip1
 
pathway with the addition of the CHCl3-F and GTE mixture. In this 
chapter, we hypothesized that the combined CHCl3-F and GTE 
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induces expression of APRIL and involves the regulation of these 
three factors, and therefore the time-dependent expression of these 
factors in HepG2 cells were examined. Our results showed that p27
Kip1
 
was increased after 2 hrs of the incubation by CHCl3-F only, 
suggesting that the effect of p27
Kip1
 by CHCl3-F appeared before the 
expression of APRIL in HepG2 cells. However, p53 and p21
Waf1/Cip1
 
were increased in the presence of the CHCl3-F and GTE mixture, and 
this effect was expressed after 8 hrs of the incubation (Fig. 4). Theses 
results suggest that the combination CHCl3-F with GTE-induced 
APRIL is not associated with p27
Kip1
 protein, but most likely with p53 
and p21
Waf1/Cip1
 proteins.  
We have previously demonstrated that extracts of green tea
 27)
, 
evening primrose
 29, 30)
, Cape aloe
 83, 84)
, Zingiberaceae plant such as 
Languas galanga and Alpinia galangal
 85)
 and Blumea balsamifera
 78)
 
have anti-cancer activities in various tumor cell lines. We have also 
demonstrated synergistic anti-cancer activity of natural substances in 
various tumor cell lines
 84, 86)
. In the present chapter, we have shown 
the different mechanisms of anti-cancer activity with treatment with 
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CHCl3-F alone and with a CHCl3-F and GTE mixture in HepG2 cells. 
Our study suggests that these natural substances have different 
anticancer activities via independent pathways in vitro, and these 
could be new tools for cancer therapy. In addition, in order to 
demonstrate whether the CHCl3-F and GTE mixture has selective 
inhibitory effects in tumor cells, its effect on hepatocytes, as a normal 
cell line, and in HepG2 cells were examined via cell viability 
dynamics. Our results showed that the CHCl3-F and GTE mixture 
exerted no cytotoxicity in rat hepatocytes, unlike in HepG2 cells. 
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5. Summary 
Our results showed that APRIL was expressed in HepG2 cells 
after 4 hrs of incubation in vitro and played an important role in cell 
proliferation. Furthermore, the anticancer activity of combination 
CHCl3-F with GTE was stronger than the CHCl3-F alone in HepG2 
cells. The mechanism of the anti-cancer activity is via reduction of the 
expression of APRIL, and involves an up-regulation of p53 and 
p21
Waf1/Cip1
 proteins in HepG2 cells. We speculate from our results that 
the CHCl3-F and GTE mixture might provide ways to new drug design 
to treat hepatocellular carcinoma in the future. 
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CONCLUSION 
 
 Natural products have played an important role throughout the 
world in treating and preventing human diseases. In this study, we 
showed that the Z. jujuba, a famous fruit in China, have anticancer 
activity in HepG2 cells. Furthermore, the chloroform fraction of Z. 
jujuba extract (CHCl3-F) was the most effective component, and was 
not only cytotoxic but had cytostatic activity as well. Also, different 
concentrations of CHCl3-F showed different growth inhibition effects 
in HepG2 cells. Apoptosis, an increase in intracellular ROS level, a 
decline of mitochondrial membrane potential at low Z. jujuba 
concentrations (100 µg/ml), and a ROS-independent mitochondrial 
dysfunction pathway at high concentrations (200 µg/ml) were all 
observed. The CHCl3-F induced not only apoptosis but also G1 arrest 
at a low concentration and G2/M arrest at a high concentration by cell 
cycle assay. CHCl3-F-induced G1 arrest in HepG2 cells was 
associated with an increase in hypophosphorylation of Rb and p27
Kip1
, 
and a decrease of phosphorylated Rb. However, CHCl3-F-induced 
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G2/M arrest in HepG2 cells was correlated with the decrease of the 
p27
Kip1
 levels and generation of the phosphorylation of p27
Kip1
, but the 
hypophosphorylation of Rb protein remained. Moreover, GTE 
enhanced selective cytotoxic activity of CHCl3-F in HepG2 cells. 
Combining CHCl3-F and GTE caused an effect on G1 phase arrest but 
not on apoptosis. Interestingly, the mechanism of the G1 arrest was 
associated, not with an increase in p27
Kip1
 levels and the 
hypophosphorylation of Rb, which are pathways of CHCl3-F on G1 
arrest in HepG2 cells, but with increases in p53 and p21
Waf1/Cip1
 levels, 
and a decrease in cyclin E levels. We also found that APRIL was 
expressed in HepG2 cells from 4 hrs of incubation in vitro and play an 
important role in cell proliferation. The mechanism of the anti-cancer 
activity of CHCl3-F and GTE mixture was via reducing the expression 
of APRIL. Decreasing APRIL involved an up-regulation of p53 and 
p21
Waf1/Cip1
 proteins in HepG2 cells.  
Our study is the first to demonstrate that CHCl3-F possesses 
anticancer activity in HepG2 cells. Furthermore, the anticancer 
activity of CHCl3-F and GTE mixture was stronger than the CHCl3-F 
 CONCLUSION 
 100 
alone in HepG2 cells. We speculate from our results that the CHCl3-F 
alone and the CHCl3-F and GTE mixture might provide a lead to new 
drug design to treat hepatocellular carcinoma in the future. 
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